ELYBRIO
Live / Applied — Extension of time to oppose received (as of 06 Feb 2026)
What this means for you
Not registered yet, but its 15 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99444768
- Mark type
- Stylized text
- Filed
- 15 Oct 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Feb 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Dec 2025 — ASSIGNED TO EXAMINER
- 15 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 15 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Oct 2025 — NEW APPLICATION ENTERED